ArticlePloS one2017

Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.

Chun-Yu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.